CAS 1177256-05-1
:R-Elvitegravir
Description:
R-Elvitegravir, with the CAS number 1177256-05-1, is a synthetic compound primarily used in the treatment of HIV as an integrase strand transfer inhibitor (INSTI). It functions by inhibiting the integrase enzyme, which is crucial for the integration of viral DNA into the host genome, thereby preventing viral replication. R-Elvitegravir is characterized by its high potency against HIV strains and is often included in combination therapies to enhance efficacy and reduce the risk of resistance. The compound exhibits favorable pharmacokinetic properties, including good oral bioavailability and a relatively long half-life, allowing for once-daily dosing in clinical settings. Additionally, it is typically formulated with a booster, such as cobicistat, to enhance its pharmacological profile. R-Elvitegravir is generally well-tolerated, with a side effect profile that may include gastrointestinal disturbances and potential interactions with other medications. Its development represents a significant advancement in antiretroviral therapy, contributing to improved outcomes for individuals living with HIV.
Formula:C23H23ClFNO5
Synonyms:- 3-Quinolinecarboxylic acid, 6-[(3-chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1R)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-
- R-Elvitegravir
- 6-[(3-Chloro-2-fluorophenyl)methyl]-1,4-dihydro-1-[(1R)-1-(hydroxymethyl)-2-methylpropyl]-7-methoxy-4-oxo-3-quinolinecarboxylic acid
Sort by
The purity filter is not visible because current products do not have associated purity data for filtering.
Found 1 products.
